Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
46.72
+0.75 (1.63%)
Oct 19, 2026, 4:00 PM EDT - Market closed
Rigel Pharmaceuticals Employees
As of December 31, 2025, Rigel Pharmaceuticals had 174 total employees, including 172 full-time and 2 part-time employees. The number of employees increased by 10 or 6.10% compared to the previous year. That makes Rigel Pharmaceuticals the 27,811th largest employer in the world and 3,510th in the United States.
Employees
174
Change (1Y)
10
Growth (1Y)
6.10%
Revenue / Employee
$1,590,718
Profits / Employee
$1,850,052
Market Cap
872.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 174 | 10 | 6.10% | 172 | 2 |
| Dec 31, 2024 | 164 | 17 | 11.56% | 162 | 2 |
| Dec 31, 2023 | 147 | -8 | -5.16% | 147 | 0 |
| Dec 31, 2022 | 155 | -10 | -6.06% | 155 | 0 |
| Dec 31, 2021 | 165 | -4 | -2.37% | 165 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 393 |
| Monte Rosa Therapeutics | 173 |
| MoonLake Immunotherapeutics | 130 |
| Cullinan Therapeutics | 109 |
| Odyssey Therapeutics | 100 |
| ArriVent BioPharma | 77 |
| Alto Neuroscience | 68 |
| Jade Biosciences | 55 |
RIGL News
- 17 hours ago - Rigel Highlights New GAVRETO® (pralsetinib) Data Across RET Fusion-Positive Cancers in Oral and Poster Presentations at ESMO Congress 2026 - PRNewsWire
- 17 days ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - Rigel Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - Rigel Pharmaceuticals Slides: H.C. Wainwright 28th Annual Global Investment Conference - Filings
- 5 weeks ago - Rigel Pharmaceuticals Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - Rigel Pharmaceuticals Slides: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Filings
- 6 weeks ago - Rigel to Participate in Upcoming September Investor Conferences - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals price target raised to $49 from $40 at Piper Sandler - TheFly